Related Experiment Videos
Effects of pneumolysin on human polymorphonuclear leukocytes and platelets
Infection and Immunity
|October 1, 1981
Summary
Pneumolysin rapidly binds to human white blood cells, stimulating some functions at low doses but causing cell death and lysis at higher concentrations. This toxin also affects platelets and activates serum, impacting immune responses.
Area of Science:
- Immunology
- Microbiology
- Toxicology
Background:
- Pneumolysin is a key virulence factor produced by Streptococcus pneumoniae.
- Understanding pneumolysin's interaction with host cells is crucial for developing effective treatments.
Purpose of the Study:
- To investigate the rapid binding of pneumolysin to human polymorphonuclear leukocytes.
- To characterize the dose-dependent effects of pneumolysin on leukocyte function and viability.
- To explore pneumolysin's impact on platelets and serum activation.
Main Methods:
- Incubation of human polymorphonuclear leukocytes with pneumolysin at 0°C.
- Assays for leukocyte migration and lysosomal enzyme secretion.
- Microscopic examination for cell death and lysis.
- Platelet aggregation and serum complement activation assays.
Main Results:
- Rapid binding of pneumolysin to polymorphonuclear leukocytes observed at low temperatures.
- Low pneumolysin concentrations stimulated leukocyte migration and enzyme release.
- High pneumolysin concentrations induced inhibition of migration, cell death, and lysis.
- Pneumolysin demonstrated lytic effects on platelets and activated serum, generating chemotaxis.
Conclusions:
- Pneumolysin exhibits complex, dose-dependent interactions with human immune cells.
- The rapid binding and varied cellular responses highlight pneumolysin's potent cytotoxic and immunomodulatory activities.
- Pneumolysin's effects on leukocytes, platelets, and serum contribute to pneumococcal pathogenesis.